SBIR/STTR Research Award
Single Cell Spatiotemporal and Functional Reporting using Magneto-Endosymbionts
Award amount
$224,679Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Bell Biosystems, Inc.
- Proposal award date
- 2015-03-23
- Contract end date
- 2015-12-23
- UEI
- Not reported
- Solicitation number
- PA13-140
- Topic code
- 100
Research abstract
DESCRIPTION provided by applicant The goal of this proposal is to further develop our magneto endosymbiont ME technology for in vivo single cell MRI detection Phase and functional reporting Phase thus creating a robust translational tool for cell based research MEs were derived from magnetic bacteria creating a living contrast agent that enables in vivo cell tracking MRI is a highly translatable technique for visualizing implanted cells because it is
non invasive and provides extremely high anatomical resolution MEs are a unique contrast agent because they have a large genetic capacity that can be leveraged to encode functional reporters in vivo The effectiveness of MEs for single cell tracking will be experimentally assessed in a metastatic brain cancer model that we have previously used to demonstrate single cell MRI tracking with superparamagnetic iron oxide particles Tools that provide insight into detailed cellular events at the single cell level in situ will advance oncology research regenerative medicine research personalized diagnostics and the clinical realization of cell therapies
PUBLIC HEALTH RELEVANCE Better translational tools for preclinical research are highly needed Understanding detailed cellular events of transplanted cells at a single cell level in situ
will advance oncology research regenerative medicine research personalized diagnostics and the clinical realization of cell therapies The achievement of this requires simultaneously addressing where are transplanted cells located i e cell tracking and what are they doing i e functional reporting Bell Biosystems Inc and the Rutt Group at Stanford University have created a unique collaboration to develop MRI based tools that enable researchers to answer these important questions
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing